<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01757522</url>
  </required_header>
  <id_info>
    <org_study_id>2012-A01204-39</org_study_id>
    <nct_id>NCT01757522</nct_id>
  </id_info>
  <brief_title>Detection of Right Ventricular Dysfunction by 2D Strain During Acute Respiratory Distress Syndrom (ARDS)</brief_title>
  <acronym>STRAIN</acronym>
  <official_title>Detection of Right Ventricular Dysfunction by 2D Strain During Acute Respiratory Distress Syndrom (ARDS)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Grenoble</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Grenoble</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Acute respiratory distress syndrome (ARDS) and mechanical ventilation can lead to right
      ventricular dysfunction and ultimately right ventricular failure by increasing pulmonary
      vascular resistances and pressure load. This can be prevented by modifying ventilator
      settings, using vasopressors or inotropes or even by prone positionning.But to do so, right
      ventricular dysfonction has to be detected. Echocardiography has emerged as a first line tool
      to diagnose right heart failure. Recently, strain analysis showed promising results to detect
      early right ventricle abnormalities in other settings such as pulmonary hypertension or
      scleroderma. We therefore decided to determine whether 2D strain could help detect early
      right ventricular dysfunction in ARDS.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>January 2013</start_date>
  <completion_date type="Anticipated">December 2016</completion_date>
  <primary_completion_date type="Anticipated">December 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Right ventricle 2D strain</measure>
    <time_frame>Duration of mechanical ventilation</time_frame>
    <description>We will assess whether 2D strain can detect a right ventricular dysfunction as compared to standard echocardiographic parameters</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mean right ventricle strain under ventilated patients</measure>
    <time_frame>at inclusion</time_frame>
    <description>We measure right ventricle strain (RV strain) in patients under mechanical ventilation for a non-respiratory cause. This allows us to determine the mean value of RV strain under ventilation when there is no respiratory failure.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reproducibility between transthoracic and transesophageal strain measures</measure>
    <time_frame>Time of mechanical ventilation</time_frame>
    <description>In ARDS patients, we record a transthoracic and transesophageal echocardiography. We compare RV strain values obtained from transthoracic and transesophageal echocardiography.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>NT pro BNP and pre pro endothelin plasma level</measure>
    <time_frame>At inclusion in ARDS patients</time_frame>
    <description>These assays are made based on the hypothesis they could help discriminate between patients who will develop a right ventricular dysfunction from those who will not. A blood sample is withdrawn at the same time as echocardiography only in the ARDS group.</description>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">290</enrollment>
  <condition>Acute Respiratory Distress Syndrome</condition>
  <condition>Right Ventricular Dysfunction</condition>
  <condition>Right Heart Failure</condition>
  <condition>Acute Cor Pulmonale</condition>
  <arm_group>
    <arm_group_label>ARDS group</arm_group_label>
    <description>Patients under mechanical ventilation since less than 24 hours at inclusion and presenting acute respiratory distress syndrome criteria.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ALI group</arm_group_label>
    <description>Patients under mechanical ventilation and presenting acute lung injury criteria.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Group</arm_group_label>
    <description>Patients under mechanical ventilation for a non-respiratory cause</description>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Plasmatic levels of NT proBNP and pre pro endothelin are monitored in ARDS group to determine
      whether these biomarkers can help detect right ventricular dysfunction.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients are recruited in our medical intensive care unit at Grenoble University Hospital.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        ARDS group

        Inclusion Criteria:

          -  Need for mechanical ventilation

          -  ARDS criteria met: Respiratory failure not fully explained by cardiac failure,
             Pao2/FiO2&lt;200, bilateral opacities on Chest imaging, all symptoms appeared within 1
             week

        Exclusion Criteria:

          -  Predictable duration of mechanical ventilation shorter than 48 hours

          -  Contraindication to transesophageal echocardiography

        ALI group:

        Inclusion Criteria:

          -  Need for mechanical ventilation

          -  ALI criteria met: Respiratory failure not fully explained by cardiac failure,
             Pao2/FiO2&lt;300, bilateral opacities on Chest imaging, all symptoms appeared within 1
             week

        Exclusion Criteria:

          -  Predictable duration of mechanical ventilation shorter than 48 hours

        Control Group:

        Inclusion Criteria:

          -  Need for mechanical ventilation for a non-respiratory cause

        Exclusion Criteria:

          -  Need for FiO2&gt;30%

          -  Known cardiac abnormalities

          -  Cardiac drugs intake during last 24 hours
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Carole SCHWEBEL, PU/PH</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Grenoble</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Carole SCHWEBEL, PU/PH</last_name>
    <phone>33-476768779</phone>
    <email>cschwebel@chu-grenoble.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>University Hospital of Grenoble</name>
      <address>
        <city>Grenoble</city>
        <state>Cedex 09</state>
        <zip>38043</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carole SCHWEBEL, PU/PH</last_name>
      <phone>33-476768779</phone>
      <email>cschwebel@chu-grenoble.fr</email>
    </contact>
    <contact_backup>
      <last_name>Cyrielle CLAPE, CRA</last_name>
      <phone>33-476767109</phone>
      <email>cclape@chu-grenoble.fr</email>
    </contact_backup>
    <investigator>
      <last_name>Carole SCHWEBEL, PU/PH</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Agnes BONADONA, PH</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Rebecca HAMIDFAR, PH</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Clemence MINET, PH</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Claire ARA SOMOHANO, PH</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Patrice FAURE, PU/PH</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Bertrand TOUSSAINT, PU/PH</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Carole SAUNIER, PH</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nicolas TERZI, PU/PH</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>March 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 4, 2012</study_first_submitted>
  <study_first_submitted_qc>December 22, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 31, 2012</study_first_posted>
  <last_update_submitted>March 14, 2016</last_update_submitted>
  <last_update_submitted_qc>March 14, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 15, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
    <mesh_term>Respiratory Distress Syndrome, Newborn</mesh_term>
    <mesh_term>Respiratory Distress Syndrome, Adult</mesh_term>
    <mesh_term>Acute Lung Injury</mesh_term>
    <mesh_term>Ventricular Dysfunction</mesh_term>
    <mesh_term>Ventricular Dysfunction, Right</mesh_term>
    <mesh_term>Pulmonary Heart Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

